4Braun J ,van der Heijde D. Novel approaches in the treatment of ankylosing spondylitis and other spondloarthritides [ J ]. Expert Opin Invesfig Drugs,2003,12 (7) :1097.
5Khan MA. U pdate on spondyloathopathy[ J]. Ann Intern M ed. 2002, 136:896.
6Gur A, Denli A, Nas K, et al. Possible pathogenetic role new cytokines in posemenopaisal osteoporosis and changes during calcitonin plus calcium therapy[ J]. Rheumatol Int ,2002,22 : 194.
7Maksymowych WP, Poole AR, Hiebert L, et al. Etanerceptexerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondyli - tis [ J ]. J Rheumatol ; 2005, 32(10) :1 911.
8Marzo- Ortega H, McGonagle D, Jarrett S, et al. Infliximab in combinationwith methotrexate in active ankylosing spondylitls: a clinical and imaging study[J]. Ann Rheum Dis,2005, 64(11 ) :1 568.
